Thalia Therapeutics plc

THAT · AIM · Health Care · mcap £10m · 0.6p 1 open situation →

EV: £8.7m
EV / EBIT: –
Net cash: £1.5m
FCF yield: -14.3%
Revenue: £7k
Share price 1y: −4%
Insiders 12m: no deals
Next report: around 22 Jun

Beta Briefing, track record and signals & risks are not ready for Thalia Therapeutics plc yet.

We follow 960 UK small caps and every one of their announcements – often hundreds per company. 101 companies are already wired into a briefing: browse them.

Timeline · every situation

dots = announcements

2026 Placing of 25% of the market value Placing of 34% of the market value Placing of 34% of the market value

Open · 1

Dilutive fundraise

Placing of 25% of the market value

completed

Thalia Therapeutics plc is raising £2,750,000 by placing, 24.8% of its market value; the shares moved +0% on the day.

30 Sep 2026 completed · +0% on the day

Open the full view – chart and every step →

Closed · 2

Dilutive fundraisePlacing of 34% of the market value completed · 24 Jun 2026 – 24 Jul 2026 +0% Dilutive fundraisePlacing of 34% of the market value completed · 25 Sep 2025 – 25 Oct 2025 −39%

Company filings. Not investment advice.